Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-11-22 10:25 CET (UTC+1h)
 

FDA guidance for bioanalytical run [Regulatives / Guidelines]

posted by samar sameh - Jordan, 2017-10-22 16:19  - Posting: # 17903
Views: 472

Dear Colleagues
I need your your help with the followings:
Regarding bioanalytical run, EMA states the following:
If the rejected calibration standard is the LLOQ, the LLOQ for this analytical run is the next lowest acceptable calibration standard of the calibration curve. If the highest calibration standard is rejected,the ULOQ for this analytical run is the next acceptable lower calibration standard of the calibration curve. The revised calibration range must cover all QC samples (low, medium and high).
Does this apply for FDA submissin, meaning:can we exclude the ULOQ and the LLOQ from calibration range ?

Samar

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,494 Posts in 3,746 Threads, 1,086 registered users;
34 users online (0 registered, 34 guests).

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed